Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1980 Sep 6;281(6241):651–653. doi: 10.1136/bmj.281.6241.651

Effect of restrictions on prescribing patterns for dextropropoxyphene.

G M Shenfield, A N Jones, J W Paterson
PMCID: PMC1714097  PMID: 7437754

Abstract

Prescribing of compound analgesics containing dextropropoxyphene was limited to consultants only in a teaching hospital. Inpatient prescribing (mainly by junior staff) fell immediately to very low levels but outpatient prescribing (by consultants) fell more slowly to about one-third of the original level, suggesting that patients and doctors find dextropropoxyphene compounds useful. Prescriptions for paracetamol increased but so did those for other compound analgesics, particularly those containing high doses of codeine, indicating a belief that compound analgesics have a role in treatment. Restrictions may produce unexpected results and monitoring is essential, but the method of audit used by pharmacies is not suitable for detailed analysis.

Full text

PDF
651

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett I. F. Letter: Misuse of propoxyphene. JAMA. 1976 Apr 19;235(16):1686–1686. doi: 10.1001/jama.235.16.1686b. [DOI] [PubMed] [Google Scholar]
  2. Christensen H. Dødelige forgiftninger med dekstropropoksifen. Ugeskr Laeger. 1975 Oct 27;137(44):2571–2576. [PubMed] [Google Scholar]
  3. Miller R. R., Feingold A., Paxinos J. Propoxyphene hydrochloride. A critical review. JAMA. 1970 Aug 10;213(6):996–1006. [PubMed] [Google Scholar]
  4. Moertel C. G., Ahmann D. L., Taylor W. F., Schwartau N. A comparative evaluation of marketed analgesic drugs. N Engl J Med. 1972 Apr 13;286(15):813–815. doi: 10.1056/NEJM197204132861504. [DOI] [PubMed] [Google Scholar]
  5. Sturner W. Q., Garriott J. C. Deaths involving propoxyphene. A study of 41 cases over a two-year period. JAMA. 1973 Mar 5;223(10):1125–1130. doi: 10.1001/jama.223.10.1125. [DOI] [PubMed] [Google Scholar]
  6. Tennant F. S., Jr Complications of propoxyphene abuse. Arch Intern Med. 1973 Aug;132(2):191–194. [PubMed] [Google Scholar]
  7. Vale J. A., Volans G. N., Crome P., Widdop B. Letter: Dextropropoxyphene poisoning. Br Med J. 1976 Aug 14;2(6032):424–424. doi: 10.1136/bmj.2.6032.424-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. WRIGHT I. S. The treatment of occlusive arterial disease. Viewpoint of an internist. JAMA. 1963 Jan 19;183:186–191. doi: 10.1001/jama.1963.63700030004014. [DOI] [PubMed] [Google Scholar]
  9. Whittington R. M. Dextropropoxyphene (Distalgesic) overdosage in the West Midlands. Br Med J. 1977 Jul 16;2(6080):172–173. doi: 10.1136/bmj.2.6080.172. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES